Nyxoah (NYXH) Total Non-Current Liabilities (2020 - 2026)
Nyxoah's (NYXH) quarterly Total Non-Current Liabilities came in at $24.2 million in Q1 2026, up 4.15% year-on-year from $23.2 million in Q1 2025, and up 1.99% quarter-over-quarter from $23.7 million in Q4 2025.
Nyxoah (NYXH) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Nyxoah's Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $24.2 million for Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 4.15% year-over-year to $24.2 million in Q1 2026; TTM through Mar 2026 was $24.2 million, a 4.15% increase from a year earlier, with the FY2025 full-year figure at $23.7 million, down 6.0% from the prior year.
- Total Non-Current Liabilities grew to $24.2 million in Q1 2026 per NYXH's latest filing, from $23.7 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $11.1 billion in Q3 2022 and bottomed at $11.1 million in Q4 2022.
- The 5-year median for Total Non-Current Liabilities is $23.2 million (2025), against an average of $756.3 million.
- Biggest YoY gain for Total Non-Current Liabilities was 130.68% in 2023; the steepest drop was 99.89% in 2023.
- Year by year, Total Non-Current Liabilities stood at $11.1 million in 2022, then increased by 13.81% to $12.6 million in 2023, then soared by 100.66% to $25.2 million in 2024, then decreased by 6.0% to $23.7 million in 2025, then increased by 1.99% to $24.2 million in 2026.
- Per Business Quant, the three latest NYXH Total Non-Current Liabilities figures stand at $24.2 million (Q1 2026), $23.7 million (Q4 2025), and $25.0 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Nyxoah | 56.02 Mn | 103.00 Mn | 4.26 Mn | 24.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.20 Mn |
| Dec 31, 2025 | 23.73 Mn |
| Jun 30, 2025 | 25.05 Mn |
| Mar 31, 2025 | 23.23 Mn |
| Dec 31, 2024 | 25.24 Mn |
| Sep 30, 2024 | 24.42 Mn |
| Jun 30, 2024 | 12.60 Mn |
| Mar 31, 2024 | 12.87 Mn |
| Dec 31, 2023 | 12.58 Mn |
| Sep 30, 2023 | 12.63 Mn |
| Jun 30, 2023 | 12.63 Mn |
| Mar 31, 2023 | 27.75 Mn |
| Dec 31, 2022 | 11.05 Mn |
| Sep 30, 2022 | 11.08 Bn |
| Mar 31, 2022 | 12.03 Mn |
| Dec 31, 2021 | 12.17 Mn |
| Dec 31, 2020 | 12.50 Mn |